MANCINI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 1.074
EU - Europa 643
AS - Asia 117
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.836
Nazione #
US - Stati Uniti d'America 1.072
IT - Italia 178
UA - Ucraina 118
IE - Irlanda 79
SE - Svezia 71
DE - Germania 52
DK - Danimarca 46
TR - Turchia 46
BE - Belgio 41
FI - Finlandia 31
KR - Corea 24
SG - Singapore 22
CN - Cina 21
GB - Regno Unito 17
GR - Grecia 4
FR - Francia 3
CA - Canada 2
IR - Iran 2
AT - Austria 1
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
Totale 1.836
Città #
Chandler 170
Fairfield 120
Jacksonville 120
Dublin 79
Ashburn 62
Wilmington 55
Houston 52
Woodbridge 46
Ann Arbor 43
Seattle 43
Brussels 39
Boardman 33
Cambridge 33
Des Moines 31
Pianella 27
Lawrence 25
Princeton 25
San Mateo 25
Turin 24
Centro 23
Porto 22
Beijing 19
Marche 9
Milan 9
San Diego 9
Helsinki 7
Catania 5
London 5
Redmond 5
Boydton 3
Civitanova Marche 3
Norwalk 3
Pistoia 3
Acton 2
Ancona 2
Athens 2
Markopoulo Mesogaias 2
Ottawa 2
Prescot 2
Tolentino 2
Venice 2
Washington 2
Agugliano 1
Auburn Hills 1
Fermo 1
Fossombrone 1
Gaiole In Chianti 1
Glendale 1
Hebei 1
Hounslow 1
Izmir 1
Kagoya 1
Kish 1
Lausanne 1
Los Angeles 1
Manila 1
Nürnberg 1
Pesaro 1
Pisa 1
Simi Valley 1
Stockholm 1
Tauranga 1
Torre Del Greco 1
Vienna 1
Wuhan 1
Totale 1.218
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 140
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 121
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 112
Glial-like differentiation potential of human mature adipocytes 104
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 99
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 94
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 86
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 84
Plasticity of human dedifferentiated adipocytes toward endothelial cells 84
Biosafety evidence for human dedifferentiated adipocytes 84
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 76
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 68
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 65
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 65
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 58
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 57
Identification of different adypocytes populations within human marrow microenvironment 56
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 54
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 54
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. 52
Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients 51
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 50
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide. 44
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 44
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 43
Ruolo degli adipociti nell’emopoiesi umana 31
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 20
A rare case of aCML associated with CNS involvement and with aggressive clinical course 13
Totale 1.909
Categoria #
all - tutte 6.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 10 28 9 5 0 1 1 2
2019/2020169 2 1 25 1 26 0 27 2 24 3 26 32
2020/2021464 11 42 35 1 100 75 86 12 34 14 41 13
2021/2022217 12 50 5 12 2 7 6 15 16 28 16 48
2022/2023494 37 65 32 40 25 73 5 32 105 3 59 18
2023/2024179 48 31 16 34 50 0 0 0 0 0 0 0
Totale 1.909